尼日利亚双相情感障碍患者对处方的挑战
Frances Nkechi Adiukwu1, Mumeen Olaitan Salihu2, Nafisatu Hayatudeen3
1Department of Mental Health, University of Port Harcourt, Port Harcourt, Rivers State, Nigeria.
BMC psychiatry
|April 1, 2025
概括
尼日利亚对双极性障碍的处方率很低,为10.89%. 关键问题包括监测和可用性,需要对指南进行审查以获得更好的患者结果.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 对双极性障碍 (BD) 有效,但其处方率在全球范围内正在下降.
- 尼日利亚用于BD的使用数据很少.
- 这项研究调查了尼日利亚精神病医生的处方率和影响因素.
研究的目的:
- 为了确定尼日利亚目前对双极性障碍的处方率.
- 确定影响尼日利亚精神病医生和实习精神病医生使用的因素.
主要方法:
- 在203名尼日利亚精神病医生和实习精神病医生中进行了横截面调查.
- 数据是在2024年4月至5月期间通过在线谷歌表格收集的.
- 该调查评估了BD不同阶段的使用情况以及影响因素.
主要成果:
- 发现的处方率很低,为10.89%.
- 虽然对临床实践指南 (CPG) 的认识与遵守相关,但它没有显著影响的处方.
- 较长的实践年龄与较高的处方相关 (p<0.001),监测/可用性是显著的问题 (p=0.032).
结论:
- 与国际基准相比,尼日利亚精神病学家和实习精神病学家的处方率较低.
- 解决监测和可用性等因素对于改善使用至关重要.
- 建议对当地临床实践指南进行审查,以与当前的证据保持一致,并提高双极性障碍的治疗结果.
相关概念视频
Mania and Antimanic Drugs: Overview
106
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
106
Bipolar Disorder
41
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
41
Psychosis: Goals of Pharmacotherapy
98
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
98
Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32
Electroconvulsive Therapy
19
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
19
Psychosis and Antipsychotic Drugs: Overview
159
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
159


